Wordt geladen...
von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3
von Willebrand disease type 2B (vWD-type 2B) is characterized by gain-of-function mutations in von Willebrand factor (vWF) that enhance its binding to the glycoprotein Ib-IX-V complex on platelets. Patients with vWD-type 2B have a bleeding tendency that is linked to loss of vWF multimers and/or thro...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3859410/ https://ncbi.nlm.nih.gov/pubmed/24270421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69458 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|